Subcutaneous, Self-Administered Methotrexate for Rheumatoid Arthritis Demonstrated Significantly Greater Bioavailability over...
June 13 2013 - 7:00AM
Business Wire
-- Study Shows Methotrexate Delivered with
an Innovative Delivery Device Achieved Significantly Greater
Bioavailability over Oral Methotrexate --
-- Data Presented at 2013 European League
Against Rheumatism (EULAR) Annual Congress in Madrid--
Antares Pharma (NASDAQ:ATRS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Antares Pharma (NASDAQ:ATRS)
Historical Stock Chart
From Oct 2023 to Oct 2024
